Skip to content

Evaluation of the phytochemical and clinical effect of herbal mixture of Pistacia Atlantica and Quercus Brantii versus placebo in Helicobacter pylori positive patients with gastritis and peptic ulcer

Evaluation of the phytochemical and clinical effect of herbal mixture of Pistacia Atlantica and Quercus Brantii versus placebo in Helicobacter pylori positive patients with gastritis and peptic ulcer: a triple-blind randomized clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120215009014N233
Enrollment
78
Registered
2018-09-03
Start date
2018-09-23
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer. Peptic ulcer, site unspecified

Interventions

Intervention 1: Intervention group: Standard triple-drug regiment for helicobacter pylori for 2 weeks plus one capsule including herbal mixture of Pistacia Atlantica and Quercus Brantii 500 mg/day for

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 80 years; Gastritis or gastric ulcer; Positive urease test

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding; Previous treatment of helicobacter pylori; Duodenal bleeding; Liver disorder; Renal failure; Heart failure; Using nonsteroidal anti-inflammatory drugs or corticosteroid and bismuth Using alcohol; Using antibiotic or antacid

Design outcomes

Primary

MeasureTime frame
Symptoms of gastritis and gastric ulcer. Timepoint: Before and 2 weeks and 3 months after intervention. Method of measurement: By history taking.;Helicobacter pylori irradiation. Timepoint: 3 months after intervention. Method of measurement: By urease test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArefeh Shojaeian

Hamedan University of Medical Sciences

a.shojaeeyan@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026